206 Factors predicting mitral restenosis after successful percutaneous mitral commissurotomy  by Bezdah, Leila et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2012) 4, 54-66 65
206
Factors predicting mitral restenosis after successful percutaneous
mitral commissurotomy
Leila Bezdah [Orateur] , Riadh Kasri, Meriem Drissa, Wafa Falah, W.
Ouechtati, N. Haddad, Slim Sidhom, Hedi Baccar
HCN, Cardiologie, Tunis, Tunisie
Introduction: Percutaneous mitral commissurotomy (PMC) is the alterna-
tive treatment of choice for mitral stenosis (MS). Its immediate and medium
term results are comparable to those of surgical commissurotomy, however in
the long term there is a risk of restenosis. The purpose of this study is to deter-
mine the factors predicting restenosis after PMC.
Methods: 322 patients (66% women), average age: 35±13 years (9-
75 years) having a tight MS and treated by PMC with Inoué balloon. The ana-
tomic aspect of the mitral apparatus before PMC has been studied according
to the criteria of the Wilkins score with a concomitant study of the state of
mitral commissures. The primary success of PMC is defined as follows: mitral
area (MA) post-PMC >1,5 cm2 and gain in MA >25% and mitral regurgitation
(MR)  grade 2. Mitral restenosis is defined as a MA <1,5 cm2 and/or loss
>50% of initial gain in MA.
Results: The rate of primary success of PMC was 86% and mean MA post PMC
was 1,82±0,33 cm² compared to MA pre-PMC of 1±0,18 cm² (p<0.0001).
Opening of two commissures has been observed in 74% of patients. After an
average period of 62±32 months, only 12% of patients had a dyspnea stage
III-IV of NYHA, MA was 1,64±0.3 cm² (p<0.001) and mitral restenosis hap-
pened in 47 patients (20%) after a period of 60,48±27 months (22-124
months).
The independent predictors of mitral restenosis after a successful PMC
were: previous surgical commisurotomy, Wilkins score >8, MA after PMC
<1,8 cm² and absence of bicommissural opening post PMC.
Conclusion: A favorable anatomy of mitral apparatus and the optimisation
of immediate result of PMC are the guaranty for the maintain of good result
in the long term.
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Closed mitral commissurotomy vs percutaneous mitral dilatation.
Long term results in patients undergoing mitral valve replacement
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Background: In countries where still rheumatic heart disease, mitral
stenosis is one of the most common valvulopathy. Mitral valve replacement is
the gold standard, however, some patients can be eligible to closed surgical or
percutaneous dilatations.
The aim of this study is to compare the long term results of both of tech-
niques in patients undergoing mitral valve replacement.
Materiel and methods: This is a retrospective study including 35 patients
who were operated for mitral valve replacement between Jan 2008 and
Sept 2010. All of them have already undergone whether closed mitral com-
missurotomy (Group 1/25 patients) or percutaneous mitral commiussurotomy
(Group 2/10 patients).
Both the long term results of mitral dilatation, and, the short term outcomes
of mitral valve replacement were studied.
Results: Events free survival was longer in CMC group (117 months vs
42 months). Mitral regurgitations observed in the first group (n=4) seemed to
have rheumatic origin, whereas those observed in the second group (n=2) were
iatrogenic.
Except bleeding, no difference was noted concerning the short term out-
comes of the mitral valve replacement.
Conclusion: In spite of its invasiveness, closed mitral commisurotomy still an
attractive therapeutic solution especially in rheumatic population. CMC results in
good long term results and don’t compromise mitral valve replacement.
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Aims: Although being a less invasive option than conventional sugery,
TAVI procedures require large bore catheters, mini-invasive surgical access
and double antiplatelet therapy. These factors might favour bleeding and neg-
atively impact subsequent prognosis in this fragile patients with high comor-
bidities. We sought to evaluate the incidence, characteristics, predictors and
prognosis impact of serious hemorrhagic complications following TAVI.
Methods: Between November 2008 and April 2011, n=112 consecutive
patients with symptomatic severe aortic stenosis underwent TAVI in our insti-
tution (83.7±6.1 y; 39% men; mean Euroscore= 21.3±10.5) using either trans-
femoral and transapical access. The primary criteria was the incidence of any
bleeding complication, according to recently proposed Valve Acadedemic
Research Consortium (VARC) criteria. 
Results: Acute procedural success rate was 98%. Serious bleeding events
were observed in 35% of patients, including n=15 VARC life-threatening/ dis-
abling (LT/D) and n=24 major bleeding events. Most of the complications
were related to access site complications (71%).
Follow-up was achieved in n=106 patients (median follow-up =7.0 months
[range: 1-24]). The mortality was significantly higher in patients with serious
events compared to patient without bleeding (p=0.02, log-rank analysis).
Although the survival didn’t significantly differ in patients with major hemor-
rhagic events (p=0.60), subjects with LT/D bleeding events had a higher mor-
tality than the subjects with no hemorrhagic complications (p<0.001, log-rank
analysis). Occurrence of VARC LT/D event following TAVI was a predictor
of all-cause mortality (HR=6.1 [2.2-16.8], p<0.001) after adjustment for other
variables in Cox regression analysis.
Conclusion: Serious bleedings are frequent following TAVI procedure and
are mainly related to local haemorrhage. VARC life-threatening/disabling
bleeding events have an impact on outcome and are associated with decreased
survival after aortic stenosis correction.
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Introduction: The wide use of PMC underlines the need to identify the
predictive factors of restenosis to guide indications.
Materials and methods: retrospective study of 170 patients, hospitalized in
the cardiology department between January 1994 and January 2008 having PMC
by balloon inoue with a clinical and echocardiographic follow-up of more than 10
years.
Results: The restenosis was defined in our study by a mitral surface low
than 1,5 cm ², it was noted in 60 patients that is 35%.The estimation of
Kaplan-Meier showed that the absence of restenosis was 87,6% in 3 years,
80% in 5 years, 72,4% in 7 years and 65,9% in 10 years.The predictive factors
of restenosis identified by the univarious analysis were:
– History of PMC ( p=0.017)
– Mitral valve area before PMC  0,8 cm² (p=0.089)
– A high echocardiographic score with a risk of restenosis multiplied by
5,5 if the score is 12(p=0.028)
– The mean pulmonary artery pressure before PMC>30 mmhg(p=0.089)
